In 40 seconds
Behavioural and psychological symptoms of dementia (BPSD) — agitation, anxiety, aggression, restlessness — affect most people with dementia at some stage. Antipsychotic medication is widely used but carries serious risks (increased stroke and mortality in dementia). Non-drug approaches are preferred where possible. PEMF therapy may support nervous system regulation and reduce agitation severity through parasympathetic activation. Patient-reported and care-home reports are positive.
Quick facts
- BPSD prevalence: Most people with dementia at some stage
- Antipsychotic risks: Increased stroke and mortality
- PEMF role: NS regulation, may reduce agitation severity
- Always with: Environmental and behavioural strategies
- Sessions: 2-3× per week, often in care setting
How PEMF may help
Modern dementia care emphasises non-drug approaches first — environment, music, reminiscence, gentle activity, structured routine. PEMF supports the underlying nervous system regulation.
Practical use
Care-home settings often run group PEMF sessions in the afternoon. Home use 2-3 sessions per week. Track agitation patterns to identify benefit.
Contraindications
Standard PEMF contraindications: pacemakers, defibrillators, cochlear implants, insulin pumps, electronic implants; active malignancy without specialist clearance; pregnancy (over the abdomen); active infection; epilepsy without GP clearance.
Frequently asked questions
Can it replace my Mum's antipsychotic?
Don't change medication without specialist input. Many families do reduce antipsychotic dose under medical guidance once PEMF and environmental strategies build effect.
Will my care home offer PEMF?
Increasingly yes, particularly in dementia-specialist homes. Ask about therapy programmes.
Looking for a PEMF clinic near you?
We list every credible PEMF therapy provider in the UK so you can find one near home.